v3.26.1
INVESTMENTS AND FAIR VALUE DISCLOSURES - Schedule of Components of the Company Investment (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Preferred equity investment, at fair value $ 310,171 $ 290,594
Equity investments in the Company’s products, equity method 79,482 67,391
Loans and deferred purchase price receivable, at amortized cost (includes $29,431 and $27,797 in the Company’s products, respectively) 60,850 58,845
Equity investments in the Company’s products, at fair value 108,545 61,906
Investments in the Company’s CLOs, at fair value 4,623 5,653
Total 563,671 484,389
Investments in Company's products    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loans and deferred purchase price receivable, at amortized cost (includes $29,431 and $27,797 in the Company’s products, respectively) $ 29,431 $ 27,797